Pathogenicity of de novo CACNA1D Ca 2+ channel variants predicted from sequence co-variation

Xuechen Tang,Nadine J. Ortner,Yuliia V. Nikonishyna,Monica L. Fernández-Quintero,Janik Kokot,Jörg Striessnig,Klaus R. Liedl

DOI: https://doi.org/10.1038/s41431-024-01594-y

2024-03-30

European Journal of Human Genetics

Abstract:Voltage-gated L-type Cav1.3 Ca 2+ channels support numerous physiological functions including neuronal excitability, sinoatrial node pacemaking, hearing, and hormone secretion. De novo missense mutations in the gene of their pore-forming α1-subunit ( CACNA1D ) induce severe gating defects which lead to autism spectrum disorder and a more severe neurological disorder with and without endocrine symptoms. The number of CACNA1D variants reported is constantly rising, but their pathogenic potential often remains unclear, which complicates clinical decision-making. Since functional tests are time-consuming and not always available, bioinformatic tools further improving pathogenicity potential prediction of novel variants are needed. Here we employed evolutionary analysis considering sequences of the Cav1.3 α1-subunit throughout the animal kingdom to predict the pathogenicity of human disease-associated CACNA1D missense variants. Co-variation analyses of evolutionary information revealed residue–residue couplings and allowed to generate a score, which correctly predicted previously identified pathogenic variants, supported pathogenicity in variants previously classified as likely pathogenic and even led to the re-classification or re-examination of 18 out of 80 variants previously assessed with clinical and electrophysiological data. Based on the prediction score, we electrophysiologically tested one variant (V584I) and found significant gating changes associated with pathogenic risks. Thus, our co-variation model represents a valuable addition to complement the assessment of the pathogenicity of CACNA1D variants completely independent of clinical diagnoses, electrophysiology, structural or biophysical considerations, and solely based on evolutionary analyses.

genetics & heredity,biochemistry & molecular biology

What problem does this paper attempt to address?

The problem that this paper attempts to solve is: how to more accurately predict the pathogenicity of de novo missense variants in the CACNA1D gene. Specifically, the CACNA1D gene encodes the α1 subunit of the voltage - gated L - type Ca²⁺ channel (Cav1.3), and these channels play important roles in physiological functions such as neural excitability, cardiac pacing, hearing, and hormone secretion. De novo missense mutations may lead to severe gating defects, which in turn can cause autism spectrum disorder (ASD) and other more severe neurological diseases, and may even be accompanied by endocrine symptoms. Currently, the number of reported CACNA1D variants is increasing continuously, but their pathogenic potential is often unclear, which brings difficulties to clinical decision - making. Since functional testing is time - consuming and not always feasible, new bioinformatics tools need to be developed to improve the prediction of the pathogenicity of new variants. To this end, the authors adopted a method based on sequence co - variation analysis, using evolutionary information to predict the pathogenicity of human disease - related CACNA1D missense variants. Through this method, they were not only able to correctly predict previously known pathogenic variants, but also supported variants previously classified as likely pathogenic, and re - classified or re - evaluated 18 out of 80 variants. In addition, they also verified a variant (V584I) through electrophysiological testing and found significant gating changes, indicating its pathogenic risk. In summary, this study aims to provide an evolutionary analysis method independent of clinical diagnosis, electrophysiology, structure, or biophysical considerations to supplement the existing CACNA1D variant pathogenicity assessment tools. ### Key points: - **Background**: De novo missense variants in the CACNA1D gene are associated with multiple neurological diseases. - **Problem**: Existing methods are difficult to accurately predict the pathogenicity of these variants, affecting clinical decision - making. - **Solution**: Use evolutionary information and sequence co - variation analysis to develop a new prediction model. - **Result**: The new model successfully predicted known pathogenic variants and improved the classification of unknown variants. In this way, researchers hope to improve the accuracy of predicting the pathogenicity of CACNA1D gene variants, thereby assisting in clinical diagnosis and treatment decision - making.

Pathogenicity of de novo CACNA1D Ca 2+ channel variants predicted from sequence co-variation

CACNA1I gain-of-function mutations differentially affect channel gating and cause neurodevelopmental disorders

A Novel De Novo Gain-of-Function CACNA1D Variant in Neurodevelopmental Disease With Congenital Tremor, Seizures, and Hypotonia

Channeling the Future of Pathogenicity Prediction for Genetic Variants in Epilepsy

Evaluation of four KCNMA1 channelopathy variants on BK channel current under CaV1.2 activation

Inactivation induced by pathogenic Cav1.3 L‐type Ca2+‐channel variants enhances sensitivity for dihydropyridine Ca2+ channel blockers

Improved classification and pathogenicity assessment by comprehensive functional studies in a large data set of KCNQ2 variants

Disruption of mitochondrial and lysosomal functions by human CACNA1C variants expressed in HEK 293 and CHO cells

Functional Characterization and Neuronal Modeling of the Effects of Childhood Absence Epilepsy Variants of CACNA1H, a T-type Calcium Channel.

Extended spectrum of idiopathic generalized epilepsies associated with CACNA1H functional variants

Epilepsy-associated SCN2A (NaV1.2) variants exhibit diverse and complex functional properties

Characterization of two pathological gating-charge substitutions in Cav1.4 L-type calcium channels

No Pain, No Gain of Function: Epilepsy-Associated Variants in SCN2A Defy Classification

Progressive Ataxia due to de novo Missense Variants in the CACNA1A Gene

Whole Exome Sequencing and Heterologous Cellular Electrophysiology Studies Elucidate a Novel Loss-of-Function Mutation in the CACNA1A-Encoded Neuronal P/Q-Type Calcium Channel in a Child with Congenital Hypotonia and Developmental Delay.

CACNA1A haploinsufficiency leads to reduced synaptic function and increased intrinsic excitability

Molecular and cellular context influences SCN8A variant function

Enhanced Classification of Brugada Syndrome-Associated and Long-QT Syndrome-Associated Genetic Variants in the SCN5A-Encoded Na(v)1.5 Cardiac Sodium Channel.

Distances from ligands as main predictive features for pathogenicity and functional effect of variants in NMDA receptors

A Pore-Localizing CACNA1C-E1115K Missense Mutation, Identified in a Patient with Idiopathic QT Prolongation, Bradycardia, and Autism Spectrum Disorder, Converts the L-type Calcium Channel into a Hybrid Nonselective Monovalent Cation Channel.

De novo mutation screening in childhood-onset cerebellar atrophy identifies gain-of-function mutations in the CACNA1G calcium channel gene